Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:

Acer Therapeutics Inc (ACER)

Acer Therapeutics Inc (ACER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Help
Go To:
Moore Kuehn Encourages TWNK, LVOX, ACER, and PNT Investors to Contact Law Firm PR Newswire - Fri Oct 13, 2023

/PRNewswire/ -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential...

TWNK : 33.30 (-0.15%)
LVOX : 3.73 (+0.81%)
ACER : 0.6601 (-17.95%)
PNT : 12.50 (+0.16%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AEL, HT, ABCM, ACER PR Newswire - Tue Oct 10, 2023

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

AEL : 56.47 (+0.55%)
HT : 9.99 (-0.10%)
ABCM : 23.99 (+0.04%)
ACER : 0.6601 (-17.95%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ABCM, AGE, ACER, NXGN PR Newswire - Mon Sep 18, 2023

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

ABCM : 23.99 (+0.04%)
AGE : 11.10 (-11.90%)
ACER : 0.6601 (-17.95%)
NXGN : 23.94 (+0.13%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates WRK, AGE, ACER PR Newswire - Tue Sep 12, 2023

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

WRK : 51.51 (+3.54%)
AGE : 11.10 (-11.90%)
ACER : 0.6601 (-17.95%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates THRN, ABCM, AGE, ACER PR Newswire - Tue Sep 5, 2023

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

THRN : 10.19 (-0.10%)
ABCM : 23.99 (+0.04%)
AGE : 11.10 (-11.90%)
ACER : 0.6601 (-17.95%)
Shareholder Alert: Ademi LLP investigates whether Acer Therapeutics Inc. has obtained a Fair Price in its transaction with Zevra PR Newswire - Thu Aug 31, 2023

/PRNewswire/ -- Ademi LLP is investigating Acer (Nasdaq: ACER) for possible breaches of fiduciary duty and other violations of law in its transaction with...

ACER : 0.6601 (-17.95%)
SWK Holdings Provides Portfolio Update Highlighting Recent Achievements PR Newswire - Tue Oct 18, 2022

/PRNewswire/ -- SWK Holdings Corporation (Nasdaq: SWKH) ("SWK" or the "Company"), a life science focused specialty finance company catering to small- and...

AZYO : 1.4900 (+2.05%)
ACER : 0.6601 (-17.95%)
BIOL : 0.0174 (-71.98%)
BTCY : 0.2776 (-11.85%)
ETON : 10.75 (+3.07%)
SWKH : 15.25 (+0.59%)
Acer Therapeutics and Relief Therapeutics Announce ACER-001 IND Submission for the Treatment of Maple Syrup Urine Disease Globe Newswire - Thu Jul 28, 2022

Phase 2a trial initiation planned for the first half of 2023 subject to IND clearance and available capital...

ACER : 0.6601 (-17.95%)
Acer Therapeutics Announces Resubmission of New Drug Application for ACER-001 for Treatment of UCDs Globe Newswire - Mon Jul 18, 2022

Acer has notified the FDA in the resubmission that the third-party contract packaging manufacturer is ready for inspection...

ACER : 0.6601 (-17.95%)
Acer Therapeutics and Relief Therapeutics Announce That the China National Intellectual Property Administration (CNIPA) Issued Utility Model Patent 11,202,767 Covering ACER-001 Dosage Form Globe Newswire - Fri Jul 8, 2022

Key patent strengthens proprietary position in China until August 2031...

ACER : 0.6601 (-17.95%)

Barchart Exclusives

2 Vaccine Stocks to Buy on the Dip Barchart - 6 minutes ago
Given the cutting-edge pipeline for these two vaccine companies, double-digit slumps in these stocks present a compelling entry point for investors. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot